Our Foundation

From Research to Real-World Impact

FLUIDIC Biosciences originated from Professor Gareth Cave’s pioneering research at Nottingham Trent University, focused on creating more physiologically relevant blood-brain barrier models. Our vision, led by Dr. Lorena Lizarraga and Professor Cave, integrates academic innovation with industry need.

Proprietary technology is protected through Nottingham Trent University’s IP portfolio, including patent application GB2403788.9. This groundbreaking work is supported by Innovate UK’s ICURe programmes, bridging laboratory innovation with commercial preclinical testing.

Discuss a project
Register your interest

About FLUIDIC Biosciences

Human-relevant data for more predictive and ethical drug development

FLUIDIC Biosciences specializes in advanced in vitro models, dynamic culture, and human-relevant testing services. Our distinctive approach integrates human cells, biomimetic nanofibre technology, and xeno-free, PDMS-free systems for enhanced predictive power and ethical drug discovery.

Our Purpose

Pioneering Xeno-Free, Predictive BBB Models

We accelerate the transition towards ethical, predictive, and human-based New Approach Methodologies, driving the development of life-saving treatments.

Contact our scientific team

Partner with FLUIDIC Biosciences

Connect with our scientific leadership to explore collaboration and partnership opportunities.